Companies / ABBV vs JNJ
ABBV vs JNJ: AbbVie and Johnson & Johnson
AbbVie (ABBV) reported $61.2B in revenue against a 6.9% net margin, while Johnson & Johnson (JNJ) reported $94.2B at a 28.5% net margin, most recently.
| Metric | ABBV | JNJ |
|---|---|---|
| Revenue | $61.2B | $94.2B |
| Net Income | $4.2B | $26.8B |
| Gross Margin | 70.2% | 67.9% |
| Operating Margin | 24.6% | — |
| EPS (Diluted) | $2.36 | $11.03 |
| Free Cash Flow | $17.8B | $19.7B |
| Total Debt | $67.0B | $49.9B |
| P/E Ratio | 96.8× | 18.8× |
| P/B Ratio | n/m | n/m |
| Stock Price | $288.14 | $272.48 |
Free: last 5 years
| Fiscal year | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $56.2B | $58.1B | $54.3B | $56.3B | $61.2B |
| JNJ Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $82.6B | $78.7B | $85.2B | $88.8B | $94.2B |